Provider: Directors Deals Ltd.
Arseus NV: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Henry Schein Inc To Acquire Five Companies From Arseus NV
Henry Schein Inc:Says it has signed an agreement to further strengthen its European dental and technology businesses.Says under the agreement, the Henry Schein will acquire 100 percent ownership of five businesses operating in three European countries from Arseus NV.Says Henry Schein did not disclose financial terms of the transaction.
Latest Developments for Arseus NV
Latest Key Developments in Medical
- Angiodynamics Inc receives FDA clearance for DuraMax Dialysis Catheter with BioFlo Technology to reduce Catheter-Related Thrombus
- Getinge AB issues Q1 2014 profit outlook below analysts' estimates
- Tandem Diabetes Care Inc gives FY 2014 revenue guidance in line with analysts' estimates
- DiaSorin SpA announces 0.55 euros per share dividend for FY 2013; issues FY 2014 revenues and EBITDA guidance
- Share this
- Digg this